Clinical Trials Browser

Pancreatic Ductal Adenocarcinoma (PDAC) × Gastrointestinal × 90 days × Clear all

NCT07301229 2025-12-24

A Phase II Clinical Study to Evaluate HLX43 in Subjects With Advanced Pancreatic Cancer

Phase 2 Not yet recruiting

Gastrointestinal

Pancreatic Ductal Adenocarcinoma (PDAC)